1. Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

   • Gwan Gyu Song
   • Young Ho Lee

   Systematic Review 26 February 2019 Pages: 421 - 428

   

2. Benefits of Beta-Blockade in Sepsis and Septic Shock: A Systematic Review

   • Young R. Lee
   • Michael Sadanand Seth
   • Hanyu Dai

   Systematic Review 08 March 2019 Pages: 429 - 440

   

3. Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

   • Rebecca E. Wrishko
   • Jacqueline B. McCrea
   • Walter K. Kraft

   Original Research Article 27 February 2019 Pages: 441 - 451

   

4. Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

   • Rebecca E. Wrishko
   • Jacqueline B. McCrea
   • Walter K. Kraft

   Correction 20 March 2019 Pages: 453 - 454

   

5. Prescribing Trends of Codeine-containing Medications and Other Opioids in Primary Care After A Regulatory Decision: An Interrupted Time Series Analysis

   • Niccolò Lombardi
   • Alfredo Vannacci
   • Francesco Lapi

   Original Research Article 09 March 2019 Pages: 455 - 462

   

6. Chronic Use of β-Blockers and the Risk of Parkinson’s Disease

   • Gideon Koren
   • Galia Norton
   • Varda Shalev

   Original Research Article 13 March 2019 Pages: 463 - 468

   

7. Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes Mellitus

   • Masayuki Kaneko
   • Mamoru Narukawa

   Original Research Article 18 March 2019 Pages: 469 - 476

8. A Phase I Open-Label Study to Evaluate the Effects of Rifampin on the Pharmacokinetics of Olanzapine and Samidorphan Administered in Combination in Healthy Human Subjects

   • Lei Sun
   • David McDonnell
   • Lisa von Moltke

   Original Research Article 19 March 2019 Pages: 477 - 484

   

9. The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?

   • Leif Hommers
   • Matthias Fischer
   • Stefan Unterecker

   Case Report 25 February 2019 Pages: 485 - 489

   

10. Early Treatment of Systemic Juvenile Idiopathic Arthritis with Canakinumab and Complete Remission After 2 Years of Treatment Suspension: Case Report of an Adolescent Girl

    • Maria Cristina Maggio
    • Saveria Sabrina Ragusa
    • Giovanni Corsello

    Case Report Open access 07 March 2019 Pages: 491 - 494